TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands
Top Cited Papers
Open Access
- 7 November 2019
- journal article
- research article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 105 (6), 1091-1101
- https://doi.org/10.1016/j.ajhg.2019.10.005
Abstract
No abstract availableKeywords
Funding Information
- Netherlands Organization for Health Research and Development (ZonMw, No. 543002001)
This publication has 43 references indexed in Scilit:
- Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencingProceedings of the National Academy of Sciences of the United States of America, 2014
- Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviewsBMC Health Services Research, 2014
- Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testingClinical Genetics, 2014
- Noninvasive Prenatal Testing Goes GlobalScience Translational Medicine, 2014
- WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison schemeNucleic Acids Research, 2013
- Low uptake of the combined test in the Netherlands – which factors contribute?Prenatal Diagnosis, 2012
- Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based studyAnnals Of Oncology, 2012
- Chromosomal mosaicisms in prenatal diagnosis: correlation with first trimester screening and clinical outcomejpme, 2012
- A case of confined placental mosaicism with double trisomy associated with stillbirthPlacenta, 2011
- Genetic screening and democracy: lessons from debating genetic screening criteria in the NetherlandsJournal of Community Genetics, 2011